In recent years, a greater awareness has emerged for protecting company intellectual property (IP) with complimentary trade secret and patent protection plans. This awareness is driven in part by the Defend Trade Secrets Act of 2016, which created a federal civil cause of action for trade secret misappropriation, and the increased scrutiny being placed on patents by the America Invents Act and case law addressing patent eligibility.
Originally published in The Pharma Letter, December 19, 2017
Related Attorneys
- Partner
- Partner